Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hers vs TeleDocs360

Hers
Graded #249

Higher grade

vs+8.699999999999996
TeleDocs360
Graded #444

Lower grade

The verdict

Hers takes it — 63.9/100 to 55.2/100.

Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Women-focused telehealth brand from Hims and Hers offering compounded semaglutide on a 6-month plan.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHers +27
54
27
Dose & formulationHers +2
77
75
Clinical oversightTeleDocs360 +13
71
84
Labs & monitoringEven
52
52
FulfillmentHers +21
81
60
Contract termsHers +21
41
20
Hers · left barTeleDocs360 · right bar

The numbers

MetricHersTeleDocs360
WeighScore63.9/10055.2/100
GradeCC
Scorecard rank#249#444
Semaglutide$199/mo (starting dose, compounded)$399/mo (compounded)
Tirzepatide$299/mo (starting dose, plus a separate fee, brand-name)$399/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
Hers

Graded #249 · C

Strengths

  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
TeleDocs360

Graded #444 · C

Strengths

  • Transparent $399/month base pricing for standard dosing
  • Multiple GLP-1 options including injectable and oral semaglutide
  • Cash-pay model with HSA/FSA card acceptance
  • Fast online intake and 24-hour prescription approval
  • Cancel anytime between shipments

Where it loses points

  • Compounded-only; no FDA-approved branded options
  • No published state availability list
  • No individual provider credentials or board certifications shown
  • Higher doses increase cost

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard